Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687763 · ClinicalTrials.gov registry record · Early Phase 1
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT02687763 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 5 participants.
The verdict
NCT02687763, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
A prospective, multisite study to evaluate the Impact of Measles, Mumps, Rubella and Varicella ProQuad® vaccination in pediatric patients 6-24 months of age who are being considered and/or evaluated for any solid organ transplant (heart, liver or kidney)
Interventions
- BIOLOGICAL ProQuad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-11-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02687763
The ClinicalTrials.gov registry entry for NCT02687763 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProQuad is the first listed.
NCT02687763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02687763 about?
NCT02687763 is a clinical study titled "Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant". A prospective, multisite study to evaluate the Impact of Measles, Mumps, Rubella and Varicella ProQuad® vaccination in pediatric patients 6-24 months of age who are being considered and/or evaluated for any solid organ transplant (heart, liver or kidney)
What is the current status of trial NCT02687763?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2015-12. Estimated completion is 2016-11-03.
What interventions are being tested in trial NCT02687763?
The interventions under investigation include: ProQuad (BIOLOGICAL).
Who is sponsoring clinical trial NCT02687763?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.